FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2099688828> ?p ?o ?g. }

• W2099688828 endingPage "680" @default.
• W2099688828 startingPage "665" @default.
• W2099688828 abstract "Advanced melanomas (non-resectable Stage-III/IV) are fatal, with few effective treatments. It remains unclear if other drugs offer improvements over the standard, dacarbazine.We quantified objective response rates (Complete+Partial response) of dacarbazine versus comparators for advanced cutaneous melanoma.We retrieved all head-to-head randomized controlled trials involving dacarbazine and other drugs/combinations. Two reviewers searched MEDLINE (1966-Jan 2006), EMBASE (1980-2006), CINAHL (1982-2006) and Cochrane library, then compared results. Differences were resolved through consensus. Rates were combined using random effects meta-analysis. chi2 tested heterogeneity; points from Jadad's method were assessed to examine study quality.We found 48 studies having 111 active treatment arms [24 with dacarbazine monotherapy (n=1390), 75 with dacarbazine combinations (n=4962), and 12 with non-dacarbazine treatments (n=783)] treating 7135 patients. Overall, study quality was poor. Response to dacarbazine monotherapy ranged between 5.3% and 28.0% (average 15.3%), OR=1.31, CI(95%): 1.06-1.61; N=3356. Partial responses comprised 73% of successes. Only adding interferons improved response rates (OR=1.69, CI(95%): 1.07-2.68, N=778) but survival duration was not significantly longer (P=0.32), and trials with larger sample sizes found lower success rates. All other treatments alone or in combination were ineffective P>0.05.Dacarbazine generally produces poor outcomes. Adding other therapies offers minimal clinical advantages (possibly with interferons). In general, study quality was poor and sample sizes were small. This meta-analysis highlights the unmet need for effective treatment options for advanced melanoma." @default.
• W2099688828 created "2016-06-24" @default.
• W2099688828 creator A5003144571 @default.
• W2099688828 creator A5013893955 @default.
• W2099688828 creator A5017439960 @default.
• W2099688828 creator A5019568971 @default.
• W2099688828 creator A5031855156 @default.
• W2099688828 creator A5078730690 @default.
• W2099688828 date "2007-12-01" @default.
• W2099688828 modified "2023-09-26" @default.
• W2099688828 title "Treatments for metastatic melanoma: Synthesis of evidence from randomized trials" @default.
• W2099688828 cites W1542940668 @default.
• W2099688828 cites W154714743 @default.
• W2099688828 cites W1752324982 @default.
• W2099688828 cites W1791289689 @default.
• W2099688828 cites W1807939285 @default.
• W2099688828 cites W1840130277 @default.
• W2099688828 cites W1879616740 @default.
• W2099688828 cites W1884609381 @default.
• W2099688828 cites W1917632054 @default.
• W2099688828 cites W1964419799 @default.
• W2099688828 cites W1969048867 @default.
• W2099688828 cites W1970556531 @default.
• W2099688828 cites W1972458901 @default.
• W2099688828 cites W1972522419 @default.
• W2099688828 cites W1972735998 @default.
• W2099688828 cites W1981576428 @default.
• W2099688828 cites W1986215651 @default.
• W2099688828 cites W1992414795 @default.
• W2099688828 cites W1997919830 @default.
• W2099688828 cites W1998502270 @default.
• W2099688828 cites W2002288639 @default.
• W2099688828 cites W2007002019 @default.
• W2099688828 cites W2008031924 @default.
• W2099688828 cites W2009153010 @default.
• W2099688828 cites W2013168041 @default.
• W2099688828 cites W2015454214 @default.
• W2099688828 cites W2020545551 @default.
• W2099688828 cites W2027905327 @default.
• W2099688828 cites W2037989832 @default.
• W2099688828 cites W2038221213 @default.
• W2099688828 cites W2039625129 @default.
• W2099688828 cites W2042295867 @default.
• W2099688828 cites W2052037617 @default.
• W2099688828 cites W2053475679 @default.
• W2099688828 cites W2068306614 @default.
• W2099688828 cites W2068529213 @default.
• W2099688828 cites W2070259449 @default.
• W2099688828 cites W2073683355 @default.
• W2099688828 cites W2078530112 @default.
• W2099688828 cites W2083851559 @default.
• W2099688828 cites W2110429401 @default.
• W2099688828 cites W2114847324 @default.
• W2099688828 cites W2122951893 @default.
• W2099688828 cites W2123138938 @default.
• W2099688828 cites W2125837906 @default.
• W2099688828 cites W2131273416 @default.
• W2099688828 cites W2135480474 @default.
• W2099688828 cites W2138239740 @default.
• W2099688828 cites W2167805334 @default.
• W2099688828 cites W2168992823 @default.
• W2099688828 cites W2245369264 @default.
• W2099688828 cites W2315123323 @default.
• W2099688828 cites W2343128466 @default.
• W2099688828 cites W2703837196 @default.
• W2099688828 cites W4210963749 @default.
• W2099688828 doi "https://doi.org/10.1016/j.ctrv.2007.06.004" @default.
• W2099688828 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17919823" @default.
• W2099688828 hasPublicationYear "2007" @default.
• W2099688828 type Work @default.
• W2099688828 sameAs 2099688828 @default.
• W2099688828 citedByCount "149" @default.
• W2099688828 countsByYear W20996888282012 @default.
• W2099688828 countsByYear W20996888282013 @default.
• W2099688828 countsByYear W20996888282014 @default.
• W2099688828 countsByYear W20996888282015 @default.
• W2099688828 countsByYear W20996888282016 @default.
• W2099688828 countsByYear W20996888282017 @default.
• W2099688828 countsByYear W20996888282018 @default.
• W2099688828 countsByYear W20996888282019 @default.
• W2099688828 countsByYear W20996888282020 @default.
• W2099688828 countsByYear W20996888282021 @default.
• W2099688828 countsByYear W20996888282022 @default.
• W2099688828 countsByYear W20996888282023 @default.
• W2099688828 crossrefType "journal-article" @default.
• W2099688828 hasAuthorship W2099688828A5003144571 @default.
• W2099688828 hasAuthorship W2099688828A5013893955 @default.
• W2099688828 hasAuthorship W2099688828A5017439960 @default.
• W2099688828 hasAuthorship W2099688828A5019568971 @default.
• W2099688828 hasAuthorship W2099688828A5031855156 @default.
• W2099688828 hasAuthorship W2099688828A5078730690 @default.
• W2099688828 hasConcept C126322002 @default.
• W2099688828 hasConcept C136524200 @default.
• W2099688828 hasConcept C143998085 @default.
• W2099688828 hasConcept C168563851 @default.
• W2099688828 hasConcept C2776478404 @default.
• W2099688828 hasConcept C2776694085 @default.
• W2099688828 hasConcept C2777658100 @default.

• next